financetom
Business
financetom
/
Business
/
Bank of Nova Scotia Fiscal Q4 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bank of Nova Scotia Fiscal Q4 Adjusted Earnings, Revenue Increase
Dec 3, 2024 3:35 AM

06:22 AM EST, 12/03/2024 (MT Newswires) -- Bank of Nova Scotia ( BNS ) reported fiscal Q4 adjusted earnings Tuesday of 1.57 Canadian dollars ($1.12) per diluted share, up from CA$1.23 a year earlier.

Analysts polled by FactSet expected CA$1.60.

Revenue for the fiscal quarter ended Oct. 31 was CA$8.53 billion, up from CA$8.27 billion a year earlier.

Analysts surveyed by FactSet expected CA$8.63 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates
May 10, 2024
11:27 AM EDT, 05/10/2024 (MT Newswires) -- Biohaven ( BHVN ) shares were falling past 11% in recent Friday trading after the company reported a Q1 adjusted net loss that missed analysts' estimates. The biopharmaceutical company reported a Q1 adjusted net loss late Thursday of $1.77 per diluted share, wider than a loss of $0.98 a year earlier. Two analysts...
Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis
Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis
May 10, 2024
May 10 (Reuters) - A Pennsylvania jury ordered ExxonMobil ( XOM ) to pay $725.5 million to a former mechanic who claimed toxic chemicals in the company's gasoline and solvents caused his cancer, according to attorneys for the plaintiff. The 10-2 verdict came on Thursday, attorneys said, after a trial in a state court in Philadelphia, where former mechanic Paul...
Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates
Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates
May 10, 2024
11:25 AM EDT, 05/10/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Iovance Biotherapeutics' ( IOVA ) shares fell 16% in recent Friday trading, a day after the company's Q1 revenue trailed estimates by analysts. The company reported a Q1 net loss late Thursday of $0.42 per diluted share, narrower than...
Baidu's Public Relations Chief Exits After Controversial Work Culture Comments
Baidu's Public Relations Chief Exits After Controversial Work Culture Comments
May 10, 2024
11:28 AM EDT, 05/10/2024 (MT Newswires) -- Baidu ( BIDU ) public relations head Qu Jing has left the company following public outcry over her comments about work culture at the Chinese internet search engine company, multiple news outlets reported Friday. Qu made comments in several short videos recently posted on Douyin, the Chinese counterpart of TikTok, that critics said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved